# Jubilant Generics Limited, Roorkee, India – FDA Inspections

Source: https://www.keypedia.com/companies/jubilant-generics-limited/0e33a821-8bc0-4f36-9264-5a108f087380

> Inspection records and compliance data for Jubilant Generics Limited in Roorkee. 10 FDA inspections on record (4 OAI), 2 Form 483s, 1 warning letter, last inspected August 01, 2025.

---

## Details

- Name: Jubilant Generics Limited
- FEI Number: 3006895982
- Facility Type: Drug Product Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: Bhagwanpur
- City: Roorkee
- Country Name: India
- Address: Bhagwanpur, Roorkee, India
- Country: India

## Related Documents

- [483 - Jubilant Generics Limited - 2025-08-01](https://www.keypedia.com/records/483/jubilant-generics-limited/39249dd0-cade-4536-8307-9474ecebe85d) — source: FDA, date: August 1, 2025
- [FDA Inspection 1278253 - Jubilant Generics Limited - 2025-08-01](https://www.keypedia.com/records/fda_inspections/jubilant-generics-limited/b8607e78-b6b9-46d7-aabe-3ff7b0c0447a) — classification: Official Action Indicated (OAI), source: FDA, date: August 1, 2025
- [483 - Jubilant Generics Limited - 2024-02-02](https://www.keypedia.com/records/483/jubilant-generics-limited/cd07e558-a1b5-46b3-8c1c-fd4afe0b5937) — source: FDA, date: February 2, 2024
- [FDA Inspection 1231774 - Jubilant Generics Limited - 2024-02-02](https://www.keypedia.com/records/fda_inspections/jubilant-generics-limited/e3324496-bfb6-4c88-b357-06d60cd2f5dd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 2, 2024
- [483 - Jubilant Generics Limited - 2022-08-01](https://www.keypedia.com/records/483/jubilant-generics-limited/a0088cb6-c47f-4c5a-b1da-68eeb86c4f8c) — source: FDA, date: August 1, 2022
- [FDA Inspection 1175958 - Jubilant Generics Limited - 2022-08-01](https://www.keypedia.com/records/fda_inspections/jubilant-generics-limited/6ce850a3-df15-4d30-baf9-989aa14d8fc8) — classification: Official Action Indicated (OAI), source: FDA, date: August 1, 2022
- [483 - Jubilant Generics Limited - 2021-03-12](https://www.keypedia.com/records/483/jubilant-generics-limited/67003c16-ec1c-4768-8d71-d52ed40b5c21) — source: FDA, date: March 12, 2021
- [FDA Inspection 1137148 - Jubilant Generics Limited - 2021-03-12](https://www.keypedia.com/records/fda_inspections/jubilant-generics-limited/fc2e71ae-4a8d-48c0-be12-652a7f9d3a86) — classification: Official Action Indicated (OAI), source: FDA, date: March 12, 2021
- [FDA Inspection 1112459 - Jubilant Generics Limited - 2019-11-06](https://www.keypedia.com/records/fda_inspections/jubilant-generics-limited/5255e726-231c-487a-93fa-bc1045ac387a) — classification: Official Action Indicated (OAI), source: FDA, date: November 6, 2019
- [483 - Jubilant Generics Limited - 2018-08-09](https://www.keypedia.com/records/483/jubilant-generics-limited/14561873-2fd1-4ab1-b5ff-284e0338186b) — source: FDA, date: August 9, 2018
- [WARNING_LETTER - Jubilant Generics Limited - 2018-08-08](https://www.keypedia.com/records/warning_letter/jubilant-generics-limited/78b01487-1252-4946-a390-b1bd324069c9) — source: FDA, date: August 8, 2018
- [FDA Inspection 1061441 - Jubilant Generics Limited - 2018-08-08](https://www.keypedia.com/records/fda_inspections/jubilant-generics-limited/f029ebb7-21d6-44c6-bb19-4f14e4a00714) — source: FDA, date: August 8, 2018
- FDA Inspection 1061441 - Jubilant Generics Limited - 2018-08-08 — source: FDA, date: August 8, 2018
- FDA Inspection 1007262 - Jubilant Generics Limited - 2017-03-23 — classification: No Action Indicated (NAI), source: FDA, date: March 23, 2017
- FDA Inspection 971357 - Jubilant Generics Limited - 2016-04-08 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 8, 2016
- [FDA Inspection 921700 - Jubilant Generics Limited - 2015-03-13](https://www.keypedia.com/records/fda_inspections/jubilant-generics-limited/c05248f9-18d0-422b-9979-52beaae66cd1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 13, 2015

## Related Companies

- [Sciegen Pharmaceuticals Inc](https://www.keypedia.com/companies/sciegen-pharmaceuticals-inc/814ff2a4-e264-431f-bffa-9932abda619d)
- [Genentech, Inc.](https://www.keypedia.com/companies/genentech-inc/97918967-ab2f-4019-9954-a0d687852d27)
- [MSD International GmbH (Puerto Rico Branch) LLC](https://www.keypedia.com/companies/msd-international-gmbh-puerto-rico-branch-llc/98d0fc68-f819-4431-899c-0483c3329777)
- [Micro Labs Limited](https://www.keypedia.com/companies/micro-labs-limited/62f2df1c-2c1e-4f8b-b4f7-40cf329f9298)
- [V-Ensure Pharma Technologies Pvt. Limited](https://www.keypedia.com/companies/v-ensure-pharma-technologies-pvt-limited/01233430-1062-49f9-ad93-adf95ab293e8)
- [Ipca Laboratories Limited](https://www.keypedia.com/companies/ipca-laboratories-limited/8357cd13-53b4-4e4d-a2a5-54b750096c7a)
- [Oxalis Labs](https://www.keypedia.com/companies/oxalis-labs/bc19741c-c2c0-43bc-80ad-91eda4acf921)
- [Emcure Pharmaceuticals Limited](https://www.keypedia.com/companies/emcure-pharmaceuticals-limited/d1295106-bf79-46f5-bf51-08338508f98e)
- [Mylan Laboratories Limited](https://www.keypedia.com/companies/mylan-laboratories-limited/b7da9cbd-d5e3-417f-a485-f9e38852b256)
- [Glenmark Pharmaceuticals Limited](https://www.keypedia.com/companies/glenmark-pharmaceuticals-limited/8a329d32-4a7d-4062-8336-1a4c9455759e)

## Related Officers

- [Rita Kabaso](https://www.keypedia.com/people/rita-kabaso/a8383d6d-b945-4edc-97a4-90944574835d)
- [Dipesh K. Shah](https://www.keypedia.com/people/dipesh-k-shah/d4df4040-13d1-477b-8c21-4c8e5b3fc5b9)
- [Consumer Safety Officer](https://www.keypedia.com/people/jeffrey-p-raimondi/7576ca4e-d9e8-4015-9ae6-9498e76058d3)
- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)
- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)
- [Marisa Heayn](https://www.keypedia.com/people/marisa-heayn/45f74410-df64-46ce-a641-72a61bfa191f)